Tango Therapeutics (TNGX) Return on Capital Employed Growth (1y) (2022 - 2026)
Tango Therapeutics (TNGX) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | -3,457.00 |
| 10 | Tango Therapeutics | 3.93 Bn | 3.77 Bn | - | 2,705.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,705.00 |
| Dec 31, 2025 | 978.00 |
| Sep 30, 2025 | -1,126.00 |
| Jun 30, 2025 | -3,495.00 |
| Mar 31, 2025 | -2,133.00 |
| Dec 31, 2024 | -1,824.00 |
| Sep 30, 2024 | -1,197.00 |
| Jun 30, 2024 | -410.00 |
| Mar 31, 2024 | -323.00 |
| Dec 31, 2023 | -277.00 |
| Sep 30, 2023 | -514.00 |
| Jun 30, 2023 | -1,156.00 |
| Mar 31, 2023 | -1,564.00 |
| Dec 31, 2022 | -1,587.00 |
| Sep 30, 2022 | -1,345.00 |
| Jun 30, 2022 | 382.00 |
| Mar 31, 2022 | 481.00 |